ArticleBioorganic & medicinal chemistry2020

10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties.

Matthew J Weaver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.